The role of lymph node sinus macrophages in host defense

2014 ◽  
Vol 1319 (1) ◽  
pp. 38-46 ◽  
Author(s):  
Mirela Kuka ◽  
Matteo Iannacone
Keyword(s):  
Lymph Node ◽  
Host Defense ◽  
Lymph Node Sinus

Role of the macrophage-inducible C-type lectin Mincle in the lung host defense against mycobacterial infections in mice

Pneumologie ◽  
2011 ◽  
Vol 65 (12) ◽  
Author(s):  
F Behler ◽  
K Steinwede ◽  
R Maus ◽  
J Bohling ◽  
UA Maus
Keyword(s):  
Host Defense ◽  
Mycobacterial Infections

The changing role of axillary lymph node dissection for breast cancer

Breast Cancer ◽  
2012 ◽  
Vol 20 (1) ◽  
pp. 41-46 ◽  
Author(s):  
Masakuni Noguchi ◽  
Emi Morioka ◽  
Yukako Ohno ◽  
Miki Noguchi ◽  
Yasuharu Nakano ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Axillary Lymph Node Dissection ◽  
Lymph Node Dissection ◽  
Axillary Lymph Node ◽  
Axillary Lymph ◽  
Node Dissection ◽  
Changing Role

67P The role of FDG PET/CT to omit sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer

2021 ◽  
Vol 32 ◽  
pp. S50
Author(s):  
E. Tanrikulu Simsek ◽  
E. Çoban ◽  
E. Atag ◽  
S. Gungor ◽  
M. Sarı ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Neoadjuvant Chemotherapy ◽  
Lymph Node Biopsy ◽  
Node Biopsy ◽  
Pet Ct ◽  
Fdg Pet Ct

scholarly journals FTY720 Blocks Egress of T Cells in Part by Abrogation of Their Adhesion on the Lymph Node Sinus

2011 ◽  
Vol 187 (5) ◽  
pp. 2244-2251 ◽  
Author(s):  
Liang Zhi ◽  
Pilhan Kim ◽  
Brian D. Thompson ◽  
Costas Pitsillides ◽  
Alexander J. Bankovich ◽  
...  
Keyword(s):  
T Cells ◽  
Lymph Node ◽  
Lymph Node Sinus

scholarly journals A New Role of Vemurafenib as a Neoadjuvant Treatment of Axillary and Brain Melanoma Metastases

2013 ◽  
Vol 2013 ◽  
pp. 1-3 ◽  
Author(s):  
Idit Melnik ◽  
Michal Lotem ◽  
Boris Yoffe
Keyword(s):  
Lymph Node ◽  
Brain Metastases ◽  
Metastatic Melanoma ◽  
Neoadjuvant Therapy ◽  
Tumor Necrosis ◽  
Neoadjuvant Treatment ◽  
Melanoma Metastases ◽  
Excisional Surgery ◽  
Complete Tumor

Vemurafenib is approved by the FDA for the management of unresectable or metastatic melanoma. However, its role as a neoadjuvant therapy has not been determined. We present the first documented case in which vemurafenib induced complete tumor necrosis of both lymph node and brain metastases within one month or less, an outcome that indicated that the patient was a good candidate for excisional surgery.

Sign in / Sign up

Export Citation Format

Share Document